Mitsuyuki Matsumoto is the founder of Arialys Therapeutics. Arialys Therapeutics has raised $58M in total funding. Latest round: Seed.
Mitsuyuki Matsumoto is a founding scientist of Arialys Therapeutics, a biotechnology company focused on precision medicines for autoimmune neuropsychiatric diseases. Arialys launched in September 2023 with $58 million in seed financing and acquired ART5803 from Astellas Pharma. Matsumoto was involved in the development of the program at Astellas Pharma before the company exited CNS research.
Full founder directory · Investor directory · Company funding database · Fundraising library